Abstract
| Original language | English |
|---|---|
| Journal | European Journal of Surgical Oncology |
| DOIs | |
| Publication status | Published - 2017 |
Fingerprint
Keywords
- Liver metastases
- Neuroendocrine tumours
- Pancreas
- Rare cancers
Cite this
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. / Lykoudis, P.M.; Partelli, S.; Muffatti, F.; Caplin, M.; Falconi, M.; Fusai, G.K.; group, RARECAREnet working; Francisci, Silvia Giovanna Luisa; tavilla, andrea; Pierannunzio, Daniela; Rossi, Silvia; Santaquilani, Mariano; Knijn, Arnold.
In: European Journal of Surgical Oncology, 2017.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours
AU - Lykoudis, P.M.
AU - Partelli, S.
AU - Muffatti, F.
AU - Caplin, M.
AU - Falconi, M.
AU - Fusai, G.K.
AU - group, RARECAREnet working
AU - Francisci, Silvia Giovanna Luisa
AU - tavilla, andrea
AU - Pierannunzio, Daniela
AU - Rossi, Silvia
AU - Santaquilani, Mariano
AU - Knijn, Arnold
N1 - Export Date: 12 April 2018 Article in Press CODEN: EJSOE Correspondence Address: Lykoudis, P.M.email: p.lykoudis@ucl.ac.uk
PY - 2017
Y1 - 2017
N2 - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. © 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.
AB - Pancreatic Neuroendocrine Neoplasms comprise a group of rare tumours with special biology, an often indolent behaviour and particular diagnostic and therapeutic requirements. The specialized biochemical tests and radiological investigations, the complexity of surgical options and the variety of medical treatments that require individual tailoring, mandate a multidisciplinary approach that can be optimally achieved through an organized network. The present study describes currents concepts in the management of these tumours as well as an insight into the challenges of delivering the pathway in and outside a Network. © 2017 Elsevier Ltd, BASO ∼ The Association for Cancer Surgery, and the European Society of Surgical Oncology.
KW - Liver metastases
KW - Neuroendocrine tumours
KW - Pancreas
KW - Rare cancers
U2 - 10.1016/j.ejso.2017.08.019
DO - 10.1016/j.ejso.2017.08.019
M3 - Article
JO - European Journal of Surgical Oncology
JF - European Journal of Surgical Oncology
SN - 0748-7983
ER -